Results 241 to 250 of about 2,109,805 (291)

Preclinical Imaging in Theranostic Applications

Nuclear Medicine Seminars
openaire   +1 more source

Clinical and Preclinical Imaging of Hepatosplenic Schistosomiasis [PDF]

Trends in Parasitology, 2020
International audienceSchistosomiasis, a neglected tropical disease, is a major cause of chronic morbidity and disability, and premature death. The hepatosplenic form of schistosomiasis is characterized by hepatosplenomegaly, liver fibrosis, portal ...
Monique Bernard, Adriana-Teodora Perles-Barbacaru, Angele Viola   +2 more
exaly   +5 more sources

Biomarkers in preclinical cancer imaging [PDF]

European Journal of Nuclear Medicine and Molecular Imaging, 2015
In view of the trend towards personalized treatment strategies for (cancer) patients, there is an increasing need to noninvasively determine individual patient characteristics.
Klazina Kooiman, Marcel Segbers, Monique R Bernsen   +2 more
exaly   +8 more sources

Some of the next articles are maybe not open access.

Related searches:

Preclinical Imaging of Cardiovascular Disesase

Seminars in Nuclear Medicine, 2023
Noninvasive imaging techniques, such as SPECT, PET, CT, echocardiography, or MRI, have become essential in cardiovascular research. They allow for the evaluation of biological processes in vivo without the need for invasive procedures. Nuclear imaging methods, such as SPECT and PET, offer numerous advantages, including high sensitivity, reliable ...
Stephan G. Nekolla, Christoph Rischpler, Takahiro Higuchi   +2 more
openaire   +2 more sources

Preclinical Imaging of siRNA Delivery

Australian Journal of Chemistry, 2016
Small interfering RNA (siRNA) is emerging as a class of therapeutic with extremely high potential, particularly in the field of oncology. Despite this growing interest, further understanding of how siRNA behaves in vivo is still required before significant uptake into clinical application.
Fletcher, Nicholas, Ardana, Aditya, Thurecht, Kristofer J.   +2 more
openaire   +4 more sources

Challenges in Imaging in Preclinical Rheumatoid Arthritis

Rheumatic Disease Clinics of North America, 2014
There exists a preclinical phase to the disease progression of rheumatoid arthritis, in which there is evidence of autoimmunity but no overt clinical arthritis. Identifying patients in this phase would allow for early treatment, to potentially halt manifestation of the disease.
Lisa A. Mandl
exaly   +3 more sources